Sage Mandel

Director/Board Member at CELYAD ONCOLOGY SA

Consumer Services

Finance

Health Technology

Profile

Sage Mandel currently works at Celyad Oncology SA, as Non-Executive Director.
Ms. Mandel also formerly worked at Essex Woodlands Management, Inc., as Vice President from 2021 to 2023.
Ms. Mandel received her graduate degree in 2015 from the University of Pennsylvania.

Sage Mandel active positions

Companies	Position	Start
CELYAD ONCOLOGY SA	Director/Board Member	-

All active positions of Sage Mandel

Former positions of Sage Mandel

Companies	Position	End
Essex Woodlands Management, Inc. Essex Woodlands Management, Inc. Investment ManagersFinance EW Healthcare Partners invests in public and private companies located in the North America, Latin America, Asia, and Europe with revenues ranges from USD 20 - 200 million. The firm focuses on sectors such as pharmaceutical, medical device, healthcare services, and healthcare IT. The firm participates in growth capital requirements with an investment size range from USD 20 - 100 million. It takes minority or majority interest and requires a board position.	Private Equity Analyst	30/12/2020

See the detail of Sage Mandel's experience

Training of Sage Mandel

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Sage Mandel's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	3
University of Pennsylvania University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Essex Woodlands Management, Inc. Essex Woodlands Management, Inc. Investment ManagersFinance EW Healthcare Partners invests in public and private companies located in the North America, Latin America, Asia, and Europe with revenues ranges from USD 20 - 200 million. The firm focuses on sectors such as pharmaceutical, medical device, healthcare services, and healthcare IT. The firm participates in growth capital requirements with an investment size range from USD 20 - 100 million. It takes minority or majority interest and requires a board position.	Finance
Celyad Oncology SA Celyad Oncology SA BiotechnologyHealth Technology Develops immuno-oncology and cardiology products	Health Technology